MARKET

ELOX

ELOX

Eloxx Pharmaceut
NASDAQ
15.13
-0.28
-1.82%
After Hours: 15.66 +0.53 +3.50% 16:18 10/06 EDT
OPEN
15.34
PREV CLOSE
15.41
HIGH
16.02
LOW
14.50
VOLUME
61.28K
TURNOVER
--
52 WEEK HIGH
23.40
52 WEEK LOW
0.0011
MARKET CAP
61.07M
P/E (TTM)
-9.9566
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ELOX last week (0928-1002)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 09/28 12:05
Weekly Report: what happened at ELOX last week (0921-0925)?
Weekly Report · 09/28 10:11
Weekly Report: what happened at ELOX last week (0914-0918)?
Weekly Report · 09/21 10:11
Eloxx Pharmaceuticals Price Target Announced at $32.00/Share by Leerink Partners
Dow Jones · 09/18 13:26
Leerink Partners Initiates Coverage On Eloxx Pharma with Outperform Rating, Announces Price Target of $32
Benzinga · 09/18 13:16
Analysts’ Top Healthcare Picks: BridgeBio Oncology Therapeutics (BBOT), Entera Bio (ENTX)
TipRanks · 09/18 12:30
Eloxx Pharmaceuticals initiated with an Outperform at Leerink
TipRanks · 09/18 10:10
More
About ELOX
Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the science of ribosome modulation, leveraging both its TURBO- ZM chemistry technology platform and its library of aminoglycosides to develop oral small-molecule ribosome modulating agents (RMAs) and eukaryotic ribosome selective glycosides (ERSGs) for the treatment of rare and ultra-rare genetic diseases. Its lead investigational product candidate, ELX-02, is a small molecule drug candidate designed to restore production of full-length functional proteins. The Company is also advancing ZKN-013 as an oral agent for the treatment of recessive dystrophic (RDEB)/ junctional epidermolysis bullosa (JEB) and familial adenomatous polyposis (FAP) patients with nonsense mutations. The Company also has preclinical programs focused on select rare diseases, including inherited diseases, cancer caused by nonsense mutations, kidney diseases, as well as rare ocular genetic disorders.

Webull offers Eloxx Pharmaceuticals Inc stock information, including NASDAQ: ELOX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELOX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELOX stock methods without spending real money on the virtual paper trading platform.